Literature DB >> 9352306

Effects of sweetening agents on morphine-induced analgesia in mice by formalin test.

S Nikfar1, M Abdollahi, F Etemad, M Sharifzadeh.   

Abstract

1. There is evidence that sweet-tasting substances such as sucrose and saccharin can interact with endogenous opioid systems. Further evidence showed that feeding mice different concentrations of sucrose and saccharin alter the latency in the tail-flick test. 2. In the current study, the effects of a 12-day regimen of different sweetening agents [sucrose (32%), saccharin (0.08%) and aspartame (0.16%)] on morphine-induced analgesia with the formalin test were investigated. 3. Male albino mice (20-27 g) were used for the experiments. Animals were given 12 days to adapt to dietary conditions. Animals were first given saline or morphine subcutaneously (1.5, 3.0, 6.0, or 9.0 mg/kg) 30 min before the observation period. The recording of the early phase started immediately and lasted for 10 min. The recording of the late response started 20 min after formalin injection and lasted for 10 min. Statistical analysis was performed by using analysis of variance followed by Newman-Keuls test, and P < or = 0.05 was considered significant. 4. Sucrose and aspartame increased morphine analgesia in the early phase, but saccharin had no effect on the early phase. On the other hand, saccharin and sucrose decreased the effect of morphine in the late phase, but aspartame increased the effect of morphine-induced analgesia. 5. In conclusion, the present data provide further evidence for an important role for dietary variables in determining the effects of exogenous opioids on pain sensitivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352306     DOI: 10.1016/s0306-3623(96)00575-7

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  8 in total

1.  A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice.

Authors:  Amber F Hoggatt; Jonathan Hoggatt; Meghan Honerlaw; Louis M Pelus
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

2.  The effect of quinine in two bottle choice procedures in C57BL6 mice: Opioid preference, somatic withdrawal, and pharmacokinetic outcomes.

Authors:  Travis W Grim; Scarlet Jinhong Park; Cullen L Schmid; Robert B Laprairie; Michael Cameron; Laura M Bohn
Journal:  Drug Alcohol Depend       Date:  2018-08-02       Impact factor: 4.492

3.  Antinociceptive actions of peripheral glucose administration.

Authors:  Rinah T Yamamoto; Wendy Foulds-Mathes; Robin B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  2013-12-10       Impact factor: 3.533

4.  Anti-inflammatory and anti-nociceptive effects of the ethanolic extracts of Alkanna frigida and Alkanna orientalis.

Authors:  H Monsef Esfahani; Z Navvab Esfahani; N Khosravi Dehaghi; A Hosseini-Sharifabad; K Tabrizian; M Parsa; Seyed Nasser Ostad
Journal:  J Nat Med       Date:  2011-11-16       Impact factor: 2.343

5.  Aspartame: Sweetener with anti-inflammatory potential?

Authors:  Sapna Pradhan; U H Shah; A G Mathur; S Sharma
Journal:  J Pharmacol Pharmacother       Date:  2010-07

6.  Oral sucrose and a pacifier for pain relief during simple procedures in preterm infants: a randomized controlled trial.

Authors:  Fathia A Elserafy; Saad A Alsaedi; Julita Louwrens; Bakr Bin Sadiq; Ali Y Mersal
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

7.  Assessment of Pain Associated with the Injection of Sodium Pentobarbital in Laboratory Mice (Mus musculus).

Authors:  John W Dutton; James E Artwohl; Xichen Huang; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-03-11       Impact factor: 1.232

8.  Kangaroo mother care diminishes pain from heel lance in very preterm neonates: a crossover trial.

Authors:  C Celeste Johnston; Francoise Filion; Marsha Campbell-Yeo; Celine Goulet; Linda Bell; Kathryn McNaughton; Jasmine Byron; Marilyn Aita; G Allen Finley; Claire-Dominique Walker
Journal:  BMC Pediatr       Date:  2008-04-24       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.